Constraints of interest: lessons at the Hospital for Sick Children.
作者信息
Phillips R A, Hoey J
出版信息
CMAJ. 1998 Oct 20;159(8):955-7.
Abstract
摘要
相似文献
1
Constraints of interest: lessons at the Hospital for Sick Children.关注的限制因素：病童医院的经验教训
CMAJ. 1998 Oct 20;159(8):955-7.
2
Legal issues surrounding privately funded research cause furore in Toronto.围绕私人资助研究的法律问题在多伦多引发了轩然大波。
CMAJ. 1998 Oct 20;159(8):983-6.
3
Industry and the academy: conflicts of interest in contemporary health research.产业界与学术界：当代健康研究中的利益冲突
Health Law J. 2002;10:103-22.
4
Academic freedom in clinical research.临床研究中的学术自由。
N Engl J Med. 2002 Oct 24;347(17):1368-71. doi: 10.1056/NEJMsb020394.
5
Independent review adds to controversy at Sick Kids.独立审查加剧了病童医院的争议。
CMAJ. 1999 Feb 9;160(3):386-8.
6
The Olivieri Report--a compelling study of the growing tensions in clinical research.《奥利维耶里报告》——一项对临床研究中日益紧张的局势进行的引人注目的研究。
Sci Eng Ethics. 2003 Jan;9(1):125-32. doi: 10.1007/s11948-003-0025-x.
7
HSC clinical trials controversy continues. Hospital for Sick Children.儿童医院的造血干细胞临床试验争议仍在继续。
Nat Med. 1999 Jan;5(1):2-3. doi: 10.1038/4667.
8
Controversial HSC clinical trials report made public. Hospital for Sick Children.有争议的造血干细胞临床试验报告公开。病童医院。
Nat Med. 1999 Jan;5(1):7. doi: 10.1038/4676.
9
Canadian whistleblower row prompts broader code of conduct.加拿大举报人事件引发更广泛的行为准则。
Nature. 1998;396(6713):715. doi: 10.1038/25431.
10
The Olivieri case: lessons for Australasia.奥利维耶里事件：给澳大拉西亚地区的教训。
J Bioeth Inq. 2005;2(2):90-105. doi: 10.1007/BF02448848.
引用本文的文献
1
Setting the IMPACT (IMProve Access to Clinical Trial data) Observatory baseline.设定 IMPACT（改善临床试验数据获取）观测站基线。
Biochem Med (Zagreb). 2018 Feb 15;28(1):010201. doi: 10.11613/BM.2018.010201.
2
Finer nuances of clinical study agreements for research trials.研究试验临床研究协议的细微差别。
Indian J Ophthalmol. 2008 Jul-Aug;56(4):267-8. doi: 10.4103/0301-4738.41409.
3
Conflict of interest in biomedical publications.生物医学出版物中的利益冲突。
Indian J Ophthalmol. 2007 Nov-Dec;55(6):409-10. doi: 10.4103/0301-4738.36471.
4
Institutional ethics review of clinical study agreements.临床研究协议的机构伦理审查。
J Med Ethics. 2004 Feb;30(1):30-4. doi: 10.1136/jme.2003.005199.
5
The controlling interests of research.研究的控股权。
CMAJ. 2002 Nov 26;167(11):1221, 1223.
6
Questions of interest.感兴趣的问题。
CMAJ. 2002 Feb 19;166(4):413, 415.
7
Ethics in exercise science research.运动科学研究中的伦理问题。
Sports Med. 2002;32(3):169-83. doi: 10.2165/00007256-200232030-00002.
8
Look, no strings: publishing industry-funded research.看，毫无限制：出版行业资助的研究。
CMAJ. 2001 Sep 18;165(6):733, 735.
本文引用的文献
1
Secrecy in science: the flock worker's lung investigation.
Ann Intern Med. 1998 Aug 15;129(4):341-4. doi: 10.7326/0003-4819-129-4-199808150-00032.
2
Iron-chelation therapy with oral deferiprone--toxicity or lack of efficacy?
N Engl J Med. 1998 Aug 13;339(7):468-9. doi: 10.1056/NEJM199808133390709.
3
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.去铁酮用于重型地中海贫血的铁螯合疗法的长期安全性和有效性
N Engl J Med. 1998 Aug 13;339(7):417-23. doi: 10.1056/NEJM199808133390701.
4
Conflict of interest in the debate over calcium-channel antagonists.钙通道阻滞剂辩论中的利益冲突。
N Engl J Med. 1998 Jan 8;338(2):101-6. doi: 10.1056/NEJM199801083380206.
5
Iron-chelation therapy with oral deferiprone in patients with thalassemia major.口服去铁酮对重型地中海贫血患者进行铁螯合治疗。
N Engl J Med. 1995 Apr 6;332(14):918-22. doi: 10.1056/NEJM199504063321404.
Zotero 插件